Med Biogene Stock Forecast, Price & News

-0.01 (-18.18 %)
(As of 10/3/2019)
Today's Range
50-Day Range
52-Week Range
Volume2,000 shs
Average Volume29,135 shs
Market CapitalizationC$596,610.00
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MBI News and Ratings via Email

Sign-up to receive the latest news and ratings for Med Biogene and its competitors with MarketBeat's FREE daily newsletter.

About Med Biogene

Med BioGene Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in identifying patients for adjuvant chemotherapy. The company has a collaboration agreement with the University Health Network in Toronto. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.


No headlines for this company have been tracked by

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Med Biogene (CVE:MBI) Frequently Asked Questions

What stocks does MarketBeat like better than Med Biogene?

Wall Street analysts have given Med Biogene a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Med Biogene wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Med Biogene's next earnings date?

Med Biogene is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Med Biogene

Who are Med Biogene's key executives?

Med Biogene's management team includes the following people:
  • Dr. Iain Weir-Jones Ph.D., P.Eng., FGS, Chairman & CEO
  • Mr. Ibrahim Ghobrial, Chief Financial Officer

Who are some of Med Biogene's key competitors?

What is Med Biogene's stock symbol?

Med Biogene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MBI."

How do I buy shares of Med Biogene?

Shares of MBI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Med Biogene's stock price today?

One share of MBI stock can currently be purchased for approximately C$0.05.

How much money does Med Biogene make?

Med Biogene has a market capitalization of C$596,610.00.

What is Med Biogene's official website?

The official website for Med Biogene is

Where are Med Biogene's headquarters?

Med Biogene is headquartered at 598 E Kent Ave South, VANCOUVER, BC V5X 4V6, Canada.

How can I contact Med Biogene?

Med Biogene's mailing address is 598 E Kent Ave South, VANCOUVER, BC V5X 4V6, Canada. The company can be reached via phone at +1-604-7327332.

This page was last updated on 8/5/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.